Cargando…
Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15
INTRODUCTION: Molecular apocrine (MA) tumors are estrogen receptor (ER) negative breast cancers characterized by androgen receptor (AR) expression. We analyzed a group of 58 transcriptionally defined MA tumors and proposed a new tool to identify these tumors. METHODS: We performed quantitative rever...
Autores principales: | Lehmann-Che, Jacqueline, Hamy, Anne-Sophie, Porcher, Raphaël, Barritault, Marc, Bouhidel, Fatiha, Habuellelah, Hanadi, Leman-Detours, Solenne, de Roquancourt, Anne, Cahen-Doidy, Laurence, Bourstyn, Edwige, de Cremoux, Patricia, de Bazelaire, Cedric, Albiter, Marcela, Giacchetti, Sylvie, Cuvier, Caroline, Janin, Anne, Espié, Marc, de Thé, Hugues, Bertheau, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053236/ https://www.ncbi.nlm.nih.gov/pubmed/23663520 http://dx.doi.org/10.1186/bcr3421 |
Ejemplares similares
-
Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen
por: Giacchetti, S, et al.
Publicado: (2014) -
Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches
por: Lehmann-Che, J, et al.
Publicado: (2011) -
Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC
por: Campedel, Luca, et al.
Publicado: (2020) -
Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy
por: Giacchetti, Sylvie, et al.
Publicado: (2022) -
Prognostic Impact of (18)FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer
por: Groheux, David, et al.
Publicado: (2012)